Chargement en cours...
Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia,
BACKGROUND: Cognitive deficits compromise quality of life and productivity for individuals with schizophrenia and have no effective treatments. Preclinical data point to the kynurenine pathway of tryptophan metabolism as a potential target for pro-cognitive drug development. We have previously demon...
Enregistré dans:
| Publié dans: | Schizophr Res |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4516229/ https://ncbi.nlm.nih.gov/pubmed/25464917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.schres.2014.10.026 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|